BACKGROUND/AIM: Progressive dysphagia is the most important symptom in inoperable cases of carcinoma of the esophagus and cardia. Treatment for the relief of dysphagia is chosen based on the lowest mortality and morbidity. This paper describes alpha consecutive series of patients with esophageal or cardial cancer, without a documented tracheoesophageal fistula, who were referred for palliative laser therapy. Alternative palliative treatments are discussed, as well as factors involved in successful laser treatment. MATERIAL AND METHODS: Over a five year period, 104 patients were treated endoscopically with the Nd-YAG laser for symptomatic improvement dysphagia caused by malignant tumors of the esophagus or cardia. RESULTS: After the initial ...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
To evaluate the effectiveness of intratumoral alcohol injection compared with Nd:YAG laser in the tr...
We reviewed the records of 732 patients with advanced esophageal carcinoma to determine the efficac...
The aim of this study was to evaluate the impact of laser palliation on symptoms such as dysphagia a...
Ten patients with unresectable esophageal malignant tumor have been managed by Nd-YAG laser palliati...
The aim of this thesis was to evaluate by means of clinical studies endoscopic Nd:YAG laser therapy ...
Since August 1984 18 patients suffering from inoperable esophageal cancer have been treated by Nd. Y...
Seven men and five women with nonresectable esophageal carcinoma were treated endoscopically with th...
26 hommes et 4 femmes, âgés de 34 à 91 ans (moyenne : 69) ont été traités : 26 cancers de l'oesophag...
The aim of our study was to compare functional outcome and survival in patients who underwent laser ...
The Authors show a set of 9 cases of patients suffering from oesophagus flaky carcinoma, judged radi...
The Nd YAG laser offers rapid relief of symptoms advanced gastrointestinal cancers but deep tumour i...
Palliation is often the only treatment that can be offered to patients affected by esophageal malign...
INTRODUCTION: Nowadays, esophagectomy and neoadjuvant-therapy is the standard care for esopahageal c...
Nous avons étudié la durée de l'intervalle libre de dysphagie chez des patients recevant ou non chim...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
To evaluate the effectiveness of intratumoral alcohol injection compared with Nd:YAG laser in the tr...
We reviewed the records of 732 patients with advanced esophageal carcinoma to determine the efficac...
The aim of this study was to evaluate the impact of laser palliation on symptoms such as dysphagia a...
Ten patients with unresectable esophageal malignant tumor have been managed by Nd-YAG laser palliati...
The aim of this thesis was to evaluate by means of clinical studies endoscopic Nd:YAG laser therapy ...
Since August 1984 18 patients suffering from inoperable esophageal cancer have been treated by Nd. Y...
Seven men and five women with nonresectable esophageal carcinoma were treated endoscopically with th...
26 hommes et 4 femmes, âgés de 34 à 91 ans (moyenne : 69) ont été traités : 26 cancers de l'oesophag...
The aim of our study was to compare functional outcome and survival in patients who underwent laser ...
The Authors show a set of 9 cases of patients suffering from oesophagus flaky carcinoma, judged radi...
The Nd YAG laser offers rapid relief of symptoms advanced gastrointestinal cancers but deep tumour i...
Palliation is often the only treatment that can be offered to patients affected by esophageal malign...
INTRODUCTION: Nowadays, esophagectomy and neoadjuvant-therapy is the standard care for esopahageal c...
Nous avons étudié la durée de l'intervalle libre de dysphagie chez des patients recevant ou non chim...
Palliative therapies in esophageal cancer Esophageal cancer is a lethal malignancy, with a rising i...
To evaluate the effectiveness of intratumoral alcohol injection compared with Nd:YAG laser in the tr...
We reviewed the records of 732 patients with advanced esophageal carcinoma to determine the efficac...